TigerGPT Answer: **Pfizer (PFE) Earnings Call Summary**
**Forecast Data:**
- **Earnings Per Share (EPS):**
- Forecast: $0.57
- Prior Year: $0.63
- Percentage Change: -9.52%
- Significance: The decrease in EPS indicates a potential decline in profitability compared to the same period last year, which could be due to increased costs or lower revenue.
- **Total Revenue:**
- Forecast: $16,955,807,310
- Prior Year: $17,763,000,000
- Percentage Change: -4.55%
- Significance: A decrease in total revenue suggests a reduction in sales or other income sources, which could impact overall financial performance.
- **EBIT (Earnings Before Interest and Taxes):**
- Forecast: $4,282,852,110
- Prior Year: $4,672,000,000
- Percentage Change: -8.33%
- Significance: The decline in EBIT indicates lower operating profitability, which could be due to higher operating expenses or lower revenue.
**Quarterly Important News:**
- No significant positive or negative news related to Pfizer's development or operations was reported over the past quarter.
**Forecast Viewpoints:**
- Current viewpoints on Pfizer's financial report are mixed, with some analysts expecting the company to meet its forecast while others are more cautious due to the declining EPS and revenue.
- Relevant articles:
- Pfizer's Q4 Earnings Preview: What to Expect
- Analysts Weigh In on Pfizer's Upcoming Earnings
**Stock Trend Analysis:**
- **Stock Price Fluctuation:** 5.60% increase from 2025-09-28 to 2025-12-27.
- **Latest Price:** $26.135 (as of 2026-01-31)
- **Support Level:** $26.11 (as of 2026-01-29)
- **Resistance Level:** $25.09 (as of 2026-01-29)
- **Analysis:** The stock price has shown a moderate increase over the past quarter. The current price is slightly above the support level, indicating potential stability. However, the resistance level is relatively close, suggesting limited upward movement unless there is a significant positive catalyst.
**Options Large Order Analysis:**
- **Call Options (Bullish):**
- PFE 20260206 26.0 call: 1600 volume
- PFE 20260130 26.0 call: 2000 volume (sell)
- PFE 20260130 26.0 call: 1600 volume (sell)
- PFE 20260320 28.0 call: 1883 volume (sell)
- PFE 20260320 28.0 call: 1848 volume (sell)
- PFE 20260320 28.0 call: 1741 volume (sell)
- **Put Options (Bearish):**
- PFE 20260618 26.0 put: 1500 volume
- PFE 20260130 25.5 put: 1500 volume (sell)
- **Analysis:** The presence of both call and put options with significant volumes indicates mixed sentiment among investors. The higher volume of call options suggests a slight bullish sentiment, but the sell orders for calls indicate caution.
**Analyst Ratings and Target Price Forecast:**
- **Analyst Ratings:**
- 4 recommend
- 8 buy
- 16 hold
- 1 sell
- **Target Price:**
- Mean: $28.91889
- Low: $23.0
- High: $37.54
- **Valuation Status:** The current stock price of $26.135 is below the mean target price, suggesting that the stock may be undervalued. However, the mixed analyst ratings indicate uncertainty about the company's future performance.
**Comprehensive Conclusion:**
Pfizer's financial forecast for the upcoming quarter shows a decline in EPS, revenue, and EBIT compared to the same period last year. The stock price has experienced moderate growth, but the presence of mixed options orders and analyst ratings suggests caution. The company may be slightly undervalued based on the target price, but the overall sentiment is uncertain. Investors should closely monitor the upcoming earnings report and any significant news that could impact the stock's performance.
**Disclaimer:**
The above content is generated by the AI robot TigerGPT and does not represent any personal views. The content is for reference only and does not constitute any investment advice.
Comments